Last Updated : November 7, 2019
Details
Project Line:
New at CADTH
News and Events
CADTH will be hosting an Evidence-to-Action event on November 27th, in collaboration with Health Quality Ontario, on accessing mental health support outside of a therapist’s office — Internet-delivered cognitive behavioural therapy (iCBT) for major depression and anxiety disorders. We will hear from patient, clinical, and expert speakers. Please register to attend the event online or in person here.
CADTH is now accepting nominations for two prestigious awards that recognize outstanding achievement and ongoing effort in the field of health technology assessment (HTA) in Canada. These awards are a wonderful opportunity to promote the importance of HTA in Canada and recognize those who are helping to improve our health care system by making evidence a cornerstone of health technology decisions. Learn more here.
CADTH invites all interested stakeholders to join its Medical Devices Portfolio Information Session on November 25th. This session will cover the role of HTA in the management of medical devices in Canada; the programs in CADTH’s medical devices and clinical interventions portfolio; the assessment processes CADTH follows; and the opportunities for input and engagement by industry, patients, and other stakeholders. Register here before November 19th.
CADTH invites all interested stakeholders to get the latest information about priority initiatives and process changes from CADTH’s pharmaceutical reviews portfolio on November 25th. Updates on other relevant CADTH initiatives will also be provided. The session also includes an open forum, where attendees can direct questions to CADTH President and CEO Dr. Brian O’Rourke and other senior staff at CADTH. Register here before November 19th.
In case you missed it, CADTH hosted a webinar on non-pharmacological interventions for chronic non-cancer pain — the science of mindfulness. View the recording here.
Drug Reimbursement Recommendations
CADTH recently issued the following CADTH Canadian Drug Expert Committee (CDEC) drug reimbursement recommendations:
- OnabotulinumtoxinA (Botox) for chronic migraine
- Insulin degludec + liraglutide (Xultophy) for type 2 diabetes mellitus
- Dolutegravir/lamivudine (Dovato) for HIV-1 infection
CADTH recently issued the following CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) drug reimbursement recommendations:
- Pomalyst in combination with dexamethasone and bortezomib for Multiple Myeloma
- Pembrolizumab (Keytruda) for Renal Cell Carcinoma
CADTH Reports
CADTH recently completed the following reports:
Horizon Scan
- Dementia Villages — Report
- Health Technology Update — Newsletter
Rapid Response Reports: Drug
- Medicinal and Synthetic Cannabinoids for Pediatric Patients: A Review of Clinical Effectiveness and Guidelines — Summary with Critical Appraisal
- Perineal Skin Cleansers for Adults with Urine Incontinence in Long-Term Care or Hospital Settings: A Review of the Clinical Effectiveness and Guidelines — Summary with Critical Appraisal
- Duration of Bisphosphonate Treatment for Patients with Osteoporosis: A Review of Clinical Effectiveness and Guidelines — Summary with Critical Appraisal
- Community Water Fluoridation Exposure: A Review of Neurological and Cognitive Effects — Summary with Critical Appraisal
- Intravenous Ketamine for Adults with Treatment-Resistant Depression or Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines —Summary with Critical Appraisal
- Medical Cannabis Use in Palliative Care: Review of Clinical Effectiveness and Guidelines —Summary with Critical Appraisal
- Codeine for Acute Pain in Patients Undergoing Orthopedic Surgery: A Review of Clinical Effectiveness — Summary with Critical Appraisal
Rapid Response Reports: Medical Devices and Systems
- Hormonal Therapy and High-Intensity Focused Ultrasonography for Prostate Cancer: Clinical Effectiveness and Guidelines — Reference List
- Risk Calculators for Prostate Cancer: Clinical Utility and Guidelines — Reference List
- Magnetic Resonance Imaging Screening for Prostate Cancer: Clinical Utility and Guidelines — Reference List
- Physical Activity for Chronic Non-Cancer Knee Pain: Clinical Effectiveness, Cost-Effectiveness and Guidelines — Reference List
- Manual Therapy for Persistent or Chronic Non-Specific Back Pain: Clinical Effectiveness, Cost-Effectiveness and Guidelines — Reference List
- Physical Therapist-Led Physical Activity for Chronic, Non-Cancer Knee Pain: Clinical Effectiveness, Cost-Effectiveness and Guidelines — Reference List
- Dental Loupes and Headlamps for Dental Care: Clinical Effectiveness, Cost-Effectiveness, and Guidelines — Summary of Abstracts
- Frequency of Eye Examinations: Guidelines — Summary of Abstracts
- Safety Needles for Insulin Pens: Clinical Effectiveness, Cost-Effectiveness, and Guidelines — Summary of Abstracts
- Aerobic Exercise for Chronic Non-Cancer Back Pain: A Review of Clinical Effectiveness — Summary with Critical Appraisal
- Acupuncture for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Cost Effectiveness and Guidelines — Summary with Critical Appraisal
- Digital Breast Tomosynthesis for the Screening and Diagnosis of Breast Cancer: A Review of the Diagnostic Accuracy, Cost-Effectiveness and Guidelines — Summary with Critical Appraisal
- Low Carbohydrate Diets for Diabetes: A Review of the Clinical Effectiveness and Guidelines — Summary with Critical Appraisal
- Screening and Diagnostic Services for People at Risk of Breast Cancer: A Rapid Qualitative Review — Summary with Critical Appraisal
Tell Us What You Think
We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.
CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.
Last Updated : November 7, 2019